Web Analytics

3 Latest Announced Rounds

  • $33,500,000
    Series B

    3 Investors

    Biotechnology Research
    Jan 14th, 2026
  • $1,863,303
    Pre-Seed

    2 Investors

    Software Development
    Jan 14th, 2026
  • $5,000,000
    Seed
    Pharmaceutical Manufacturing
    Jan 14th, 2026
$2,498.16M Raised in 48 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Encellin

start up
United States - Mountain View
  • 14/12/2023
  • Unknown
  • $9,900,000

Encellin is focused on advancing next generation therapies, starting with endocrine disorders.

We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases.


Related People

Crystal NyitrayFounder

Crystal Nyitray United States - San Francisco, California

N/A